B. Crestani (Paris, France), J. Behr (Bochum, Germany)
Mutations in SFTPC, SFTPA2 and TERT explain 60% of familial pulmonary fibrosis and correlate to specific disease phenotypes
C. van Moorsel, J. van der Vis, M. van Oosterhout, H. Ruven, P. de Jong, W. van Es, J. van den Bosch, J. Grutters (Nieuwegein, Utrecht, Netherlands)
|  |
Association between polymorphisms in the P53 and P21 genes and IPF
N. Korthagen, C. van Moorsel, K. Kazemier, J. Grutters (Nieuwegein, Utrecht, Netherlands)
|  |
Genetic variability in the IL1RN gene and the balance between IL1-Ra and IL-1β in IPF
N. Barlo, C. van Moorsel, N. Korthagen, M. Heron, G. Rijkers, H. Ruven, J. van den Bosch, J. Grutters (Nieuwegein, Netherlands)
| |
The relationship of IL-4 cytokine gene polymorphisms, HRCT and histopathological score in patients with idiopathic pulmonary fibrosis
M. Vasakova, M. Sterclova, R. Matej, L. Kolesar, J. Skibova, I. Striz (Prague, Czech Republic)
| |
Familial idiopathic pulmonary fibrosis and "genetic anticipation"
C. Ravaglia, S. Tomassetti, G. Casoni, M. Romagnoli, C. Gurioli, C. Gurioli, S. Piciucchi, V. Poletti (Forlì, Italy)
| |
Association of single nucleotide polymorphisms in 4 genes (VDR, COL1A1, CALCR and BGLAP) with susceptibility to steroid osteoporosis in patients with idiopathic pulmonary fibrosis (IPF)
A. Ulitina, D. Dzadzua, L. Novikova, I. Pavlenko, J. Ilkovich, M. Dubina (Saint-Petersburg, Russian Federation)
| |
The genetic polymorphism of metalloproteinases MMP2, 7, 9 and MMP inhibitor TIMP2 in sarcoidosis
W. J. Piotrowski, P. Górski, T. Pietras, J. Szemraj (Lodz, Poland)
| |
Dose-dependent pro- or anti-proliferative effects of calcineurin inhibitors in bronchiolitis obliterans following allogeneic stem cell transplantation
K. Hostettler, J. Halter, D. Lardinois, M. Roth, M. Tamm (Basel, Switzerland)
| |
Enhanced expression of Fas ligand (FasL) in fibrotic interstitial lung diseases (ILDs). The possible role of membrane-bound FasL form
P. Kopinski, A. Dyczek, B. Balicka-Slusarczyk, G. Przybylski, J. Chorostowska-Wynimko, A. Szpechcinski, T. Iwaniec, K. Szablowska, J. Szczeklik (Bydgoszcz, Kracow, Warsaw, Poland)
| |
Heme oxygenase–1 induced by quercetin attenuates TGF-β-stimulated collagen production in fibroblasts
T. Kawabe, T. Nakamura, M. Matsushima, Y. Hayashi, M. Shibasaki, K. Imaizumi, N. Hashimoto, K. Shimokata, Y. Hasegawa (Nagoya, Japan)
| |
Different expression pattern of endothelin receptors in primary human lung fibroblasts derived from idiopathic pulmonary fibrosis compared to healthy controls
K. Hostettler, J. Zhong, M. Tamm, D. Lardinois, M. Roth (Basel, Switzerland)
| |
Role of phosphatidylinositol-3-kinase (PI3K) in TGF-β-induced proliferation and differentiation of human lung fibroblasts into myofibroblasts
E. Conte, M. Fruciano, E. Fagone, E. Gili, M. Iemmolo, N. Crimi, C. Vancheri (Catania, Italy)
| |
Inhibition of TGF- β 1-induced extracellular matrix production in primary human pulmonary fibroblasts by rapamycin
Y. Gao, H. P. Dai, X. F. Xu, K. Ding (Beijing, China)
| |
Familial cases of idiopathic pulmonary fibrosis: Clinical observation
L. Novikova, Y. Ilkovich, M. Ilkovich (Saint-Petersburg, Russian Federation)
| |
Paraquat-induced epithelial-mesenchymal transition: Role of Rac1b/Akt/Twist
S. Yongchun, Z. Xiaohong, Y. Ting, W. Tao, W. Fuqiang (Chengdu, China)
| |
The prevalence of neoplastic transformation in idiopathic pulmonary fibrosis (IPF) lungs. A report from a transplanted IPF population
E. Balestro, E. Rossi, F. Lunardi, N. Nannini, M. Loy, F. Rea, M. Saettta, F. Calabrese (Padua, Italy)
| |